Cannabis News
Authoritative coverage of the global cannabis industry — regulation, investment, markets and policy, reported for the people who run it.
Cannabis News · page 55
- Data & Analysis
From Page to Platform: Prohibition Partners Unveils Interactive Cannabis Intelligence Hub
Prohibition Partners will soon be launching the 10th addition of their industry leading European Cannabis Report, marking the milestone with a ground-up overhaul of its tried and trusted format.
- Markets & Stocks
Celadon Announces Intention to Delist amid Exodus of Directors, Allied Corp Lays Out Future Plans, & Chill Brands Delays Financial Results Again
Celadon Pharmaceuticals [stock_market_widget type=”chart” template=”line” assets=”CEL.L” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] Celadon Pharmaceuticals has become the latest major European publicly listed cannabis company to announce plans to de-list its shares from the London Stock Exchange.
- Uncategorized
Virginia’s Governor Controversially Vetoes Adult-Use Cannabis Legalization for Second Consecutive Year
Virginia Governor Glenn Youngkin has, for the second year in a row, vetoed legislation that would have created a regulated framework for adult-use cannabis sales.
- Markets & Stocks
How Will Trump’s ‘Super Bowl’ of Tariffs Impact US Cannabis
‘Liberation day’, set to take place on April 02, has been pitched as the day the Trump administration will roll out sweeping and aggressive tariffs for all of the US’ trading partners.
- Uncategorized
‘Intoxicating Hemp’ Market Under Threat of Extinction Following 7-Year Boom
The freewheeling days for hemp-derived THC in America appear to be dwindling.
- Your #1 Podcast on Cannabis News
Business of Cannabis: Podcast | Releaf x Glass Pharms
The second in our series of guest episodes features a discussion between CEO of Releaf, Tim Kirby, and James Duckenfield, CEO of Glass Pharms.
- Medical
Delayed but Not Denied: France Finally Unveils Full Medical Cannabis Blueprint
France’s four-year campaign to launch a fully regulated generalised medical cannabis framework is finally being realised.
- Uncategorized
Texas Senate Approves Controversial Blanket Ban on THC
Texas has taken one step closer to becoming the latest US state to impose a blanket ban on intoxicating hemp products, a move which could destroy ‘90-95%’ of the state’s thriving hemp industry.
- Companies
The Rise of Multi-Country Operators: Somai Targets 20 Countries by Year End
Multi-state operators, or MSO’s, have long represented the biggest and most influential cannabis players in North America. Yet, as that market matures and expansion opportunities dwindle a new trend is emerging – the rise of ‘multi-country operators’ (MCOs).
- Markets & Stocks
Celadon’s Funding Woes Continue, DanCann Pharma Partners with Tetra Pharma, & Argent Bio Posts Positive Clinical Trial Results
UK-listed medical cannabis producer Celadon Pharmaceuticals is struggling to emerge from its precarious financial position after months of turmoil.
- Adult-Use
North Carolina and Idaho Introduce Major Cannabis Reform Bills
North Carolina and Idaho could both soon see major cannabis reform after adult-use legalization and medical cannabis bills were introduced respectively.
- Uncategorized
Canada’s Cannabis Market: Study Reveals Price, Not Store Count, Drives Usage Trends
The price of cannabis has a more significant effect on consumer behaviour than store count, according to a newly published study on the Canadian cannabis market.
